Insulet Corporation appointed Michael R. Minogue and James C. Mullen to the company’s board. Minogue is CEO, president and chairman of Abiomed. He previously served with GE Healthcare, where he holds three patents and spent 11 years in sales, marketing, product development, information technologies and software/service operations. He currently serves on the board of AdvaMed and as chairman of the Medical Device Innovation Consortium. Mullen is CEO of Patheon, which recently announced an agreement to be acquired by Thermo Fisher Scientific.